GlassScriptPhysician profile
Risha M Foster
NPI 1376706630
$8,850.71
in general payments reported to CMS, 2019-2025
57 companies · $1,665 in 2025
The $1,665 reported for 2025 was more than what 75% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,493 · 2020: $423 · 2021: $921 · 2022: $1,137 · 2023: $1,648 · 2024: $1,565 · 2025: $1,665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,744 · Education: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,744.42 |
| Education | $133.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,277.05 | 2019-2025 | Xtandi, Myrbetriq, Padcev |
| Abbvie INC. | $779.74 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $448.00 | 2023-2025 | Orgovyx, Gemtesa |
| Dendreon Pharmaceuticals LLC | $445.87 | 2019-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $368.58 | 2019-2025 | |
| Pfizer INC. | $362.37 | 2019-2025 | |
| Janssen Biotech, INC. | $333.61 | 2019-2025 | Erleada |
| Coloplast Corp | $266.17 | 2019-2023 | Isiris Astent Removal Device |
| Novartis Pharmaceuticals Corporation | $252.39 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $243.20 | 2020-2024 | Lynparza |
| 180 Medical, INC. | $232.86 | 2019-2025 | |
| Allergan, INC. | $230.70 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $227.79 | 2020-2024 | Keytruda, Lynparza, Welireg |
| Myriad Genetic Laboratories, INC. | $192.43 | 2022-2024 | Prolaris |
| Zyla Life Sciences, INC. | $189.91 | 2019-2020 |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $188.12 | 2019-2025 | Adstiladrin |
| Blue Earth Diagnostics | $184.22 | 2019-2025 | Posluma |
| Urogen Pharma, INC. | $180.82 | 2023-2025 | Jelmyto |
| Antares Pharma, INC. | $176.48 | 2021-2023 | Nocdurna, Tlando, Xyosted |
| Boston Scientific Corporation | $171.86 | 2019-2025 | General - Kidney Stone Disease |
| Laborie Medical Technologies Corp. | $162.82 | 2020-2024 | Urgent PC Neuromodulation System, Optilume Bph Drug Coated Balloon Catheter |
| Convatec INC. | $160.48 | 2021-2024 | |
| Olympus America INC. | $157.92 | 2019-2025 | Uretero-Reno Videoscope, Itind System |
| Axonics, INC. | $145.66 | 2021-2023 | Axonics, Bulkamid |
| Accord Healthcare, INC. | $128.58 | 2023-2024 | |
| Progenics Pharmaceuticals, INC. | $99.01 | 2025 | |
| Rochester Medical Corporation | $90.94 | 2019-2021 | |
| Tolmar, INC. | $84.52 | 2023-2025 | Eligard |
| Tolmar Pharmaceuticals, INC. | $75.31 | 2019-2022 | |
| Endo USA, INC. | $73.60 | 2024-2025 | Xiaflex |
| Travere Therapeutics, INC. | $69.50 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $67.33 | 2019-2023 | Bard Urinary Drainage Bag |
| Procept Biorobotics Corporation | $62.38 | 2023-2025 | Aquabeam Robotic System |
| Myovant Sciences INC. | $61.27 | 2022 | |
| Mission Pharmacal Company | $50.28 | 2019-2023 | Uribel |
| Halozyme INC | $48.60 | 2023 | |
| Becton, Dickinson and Company | $47.29 | 2022 | |
| Immunitybio, INC. | $45.83 | 2025 | |
| Urovant Sciences INC | $45.30 | 2021-2022 | |
| Hollister Incorporated | $45.03 | 2023 | Vapro, Infyna Chic, Onli |
| Endo Pharmaceuticals INC. | $43.97 | 2019-2020 | |
| Verity Pharmaceuticals INC. | $35.13 | 2024-2025 | Trelstar |
| Kowa Pharmaceuticals America, INC. | $34.48 | 2023 | Seglentis |
| Telix Pharmaceuticals | $32.47 | 2025 | Illuccix |
| Kerecis Limited | $27.65 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Clarus Therapeutics INC. | $26.43 | 2021 | |
| Avation Medical, INC. | $23.38 | 2025 | Vivally System |
| Amgen INC. | $23.20 | 2022 | |
| Calyxo, INC. | $22.76 | 2024 | Cvac Aspiration System |
| Bluewind Medical | $21.89 | 2024 | Revi |
| Profound Medical Corp. | $19.97 | 2025 | Tulsa-Pro |
| Medtronic, INC. | $18.98 | 2025 | Interstim |
| Dentsply Ih INC. | $16.50 | 2022 | |
| Cook Medical LLC | $16.48 | 2024 | Cook |
| Dentsply Ih Ab | $13.60 | 2025 | Lofric |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$340,124.48 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Risha Foster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.